Volume 4, Issue 2 (12-2022)                   PBP 2022, 4(2): 89-102 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Akhzari M, Shabani-Borujeni M, Tavakoli R, Siahkohi H, Mottaghiyan Z, Fathi J, et al . Zingiber officinale (Ginger) properties in clinical trials; a brief review. PBP 2022; 4 (2) :89-102
URL: http://pbp.medilam.ac.ir/article-1-165-en.html
Department of Clinical Biochemistry, Faculty of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran , shafieem@sums.ac.ir
Abstract:   (314 Views)
Objective: Zingiber officinale (Ginger) is a flowering plant that was once utilized in Chinese medicine, Indian medicine, and Greek herbal therapy to treat many illnesses.
Results: Different parts of this plant, for example, roots and rhizomes, and its extract are widely used as a spice and traditional medicine. It has been shown that ginger has several therapeutic properties, including reducing inflammation, preventing cancer, lowering blood sugar and lipids, regulating the immune system, anti-apoptotic and anti-nausea, and anti-vomiting effects. In addition, nervous diseases, colds, rheumatism, gingivitis, toothaches, asthma, stroke, constipation, and diabetes have been treated with ginger. Ginger is also a powerful antioxidant and can prevent the production and activity of free radicals. Moreover, ginger extract has been utilized as a diaphoretic and anti-flatulent medication for gastrointestinal spasms. It's also used to treat indigestion and colic pain in the intestines.
Conclusion: In this contribution, we provide an overview of various reports of ginger properties in clinical studies and its effects on the treatment of diseases. In addition to summarizing the present literature. This study highlights the potential of this field to open up new avenues for researchers.
 
Full-Text [PDF 5540 kb]   (24 Downloads)    
Type of Study: Research | Subject: Herbal Drugs
Received: 2022/11/22 | Accepted: 2022/11/23 | Published: 2022/11/23

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.